Venus Medtech (Hangzhou), Inc. Class H - PE Ratio

The PE Ratio as of August 2026 (TTM) for Venus Medtech (Hangzhou), Inc. Class H (VMTHF) is -3.24

According to Venus Medtech (Hangzhou), Inc. Class H’s latest financial reports and current stock price. The company's current PE Ratio is -3.24. This represents a change of 94.08% compared to the average of -1.67 of the last 4 quarters.

Venus Medtech (Hangzhou), Inc. Class H (VMTHF) Historical PE Ratio (quarterly & annually)

How has VMTHF PE Ratio performed in the past?

The mean historical PE Ratio of Venus Medtech (Hangzhou), Inc. Class H over the last ten years is -39.96. The current -3.24 PE Ratio has changed 710.89% with respect to the historical average. Over the past ten years (40 quarters), VMTHF's PE Ratio was at its highest in in the December 2025 quarter at -0.86. The PE Ratio was at its lowest in in the January 2017 quarter at -95.34.

Venus Medtech (Hangzhou), Inc. Class H (VMTHF) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Venus Medtech (Hangzhou), Inc. Class H PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Venus Medtech (Hangzhou), Inc. Class H (VMTHF) Average PE Ratio

How has VMTHF PE Ratio performed in the past?

The current PE Ratio of Venus Medtech (Hangzhou), Inc. Class H (VMTHF) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Venus Medtech (Hangzhou), Inc. Class H (VMTHF) PE Ratio vs. Peers

How is VMTHF’s PE Ratio compared to its peers?

Venus Medtech (Hangzhou), Inc. Class H’s PE Ratio is less than MedX Health Corp (-1.85), less than Avita Medical Inc. (-0.12), less than BICO Group AB (publ) (-1.11), less than BICO Group AB (publ) (-1.11), less than 3-D Matrix, Ltd. (9.92), greater than Paxman AB (publ) (-101.45), greater than Implanet S.A. (-5.52), less than Jushi Holdings Inc. (-1.23), less than Molecular Partners AG (-2.10), greater than Santhera Pharmaceuticals Holding AG (-3.91),

Build a custom stock screener for Venus Medtech (Hangzhou), Inc. Class H (VMTHF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Venus Medtech (Hangzhou), Inc. Class H using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Venus Medtech (Hangzhou), Inc. Class H (VMTHF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Venus Medtech (Hangzhou), Inc. Class H or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.